Viewing Study NCT00184002


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-11 @ 2:35 PM
Study NCT ID: NCT00184002
Status: COMPLETED
Last Update Posted: 2017-08-10
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
Sponsor:
Organization: